Appointment of Non-Executive Director – Mary Sontrop
5 March 2021
ASX ANNOUNCEMENT
Appointment of Non-Executive Director – Mary Sontrop
Medical Developments International Limited (ASX: MVP) is pleased to announce the appointment of Ms. Mary Sontrop as a Non-Executive Director of the Company with immediate effect.
Mary has extensive international experience in the biopharmaceutical sector across manufacturing operations, quality, and business integration. During her 28 years with CSL Limited (ASX: CSL), Mary was an integral part of CSL’s globalisation through a series of major acquisitions. This included primary responsibility for the turnaround of unprofitable manufacturing operations. Subsequently as head of global plasma manufacturing, Mary delivered a globally integrated manufacturing network spanning four countries. As head of CSL’s Australia and New Zealand pharmaceutical business, Mary and her team delivered Australia’s most successful adolescent/adult immunisation program and achieved USFDA (US Food & Drug Administration) approval to manufacture and export CSL’s seasonal and pandemic influenza vaccines.
Mary holds a Bachelor of Applied Science, Graduate Diplomas in Quality Management and Administration (Health) and a Master of Business Administration. Mary is an experienced non-executive director (currently on the Board of IDT Australia Ltd (ASX: IDT)) and a Graduate of the Australian Institute of Company Directors. She also has significant international governance experience.
Mary said: “Whilst I recognise that MVP is going through a challenging period of change, I am very much looking forward to working with the Company Board and management to realise the international potential of this Australian technology”.
MVP Company Chair, Mr. Gordon Naylor said: “Mary joins at a critical time for the company. I am confident that she will strengthen the Board and readily bring valuable experience and counsel to the Company”.
Enquiries:
Mark Edwards
Company Secretary
+61 (3) 9547 1888